Company: RGNX
Filing Date: 2025-03-13
Form Type: 10-K
Source: 0000950170-25-038770
Chunk: 229

Company: REGENXBIO Inc.
Filing Date: 2025-03-13
Form: 10-K
Item: Item 1B
Chunk 229
---
    6,101

    (414
    )

    137

    Other non-cash adjustments

    1,324

    319

    231

    Changes in operating assets and liabilities

    Accounts receivable

    9,707

    3,935

    4,822

    Prepaid expenses

    5,453

    (620
    )

    4,852

    Other current assets

    6,511

    (10,546
    )

    247

    Operating lease right-of-use assets

    6,196

    5,761

    4,450

    Other assets

    807

    1,590

    31

    Accounts payable

    (292
    )

    (2,791
    )

    18,790

    Accrued expenses and other current liabilities

    (12,124
    )

    2,452

    (25,616
    )

    Deferred revenue

    (33
    )

    (1,512
    )

    (1,165
    )

    Operating lease liabilities

    (8,083
    )

    (6,641
    )

    (544
    )

    Other liabilities

    (2,609
    )

    (2,515
    )

    8,110

    Net cash used in operating activities

    (173,125
    )

    (218,407
    )

    (207,488
    )

    Cash flows from investing activities

    Purchases of marketable debt securities

    (190,139
    )

    (86,564
    )

    (184,875
    )

    Maturities of marketable debt securities

    290,238

    285,492

    203,146

    Sales of equity securities

    5,783

    1,975

    524

    Purchases of property and equipment

    (2,436
    )

    (9,960
    )

    (30,724
    )

    Net cash provided by (used in) investing activities

    103,446

    190,943

    (11,929
    )

    Cash flows from financing activities

    Proceeds from exercise of stock options

    1,512

    1,521

    2,804